BigClassActions.com
Advertisement

Imperva, Inc. IMPV Securities Lawsuit

- by

Company: Imperva, Inc.
Ticker Symbol: IMPV
Class Period: May-2-13 to Apr-9-13
Date Filed: Apr-9-13
Lead Plaintiff Deadline: Jun-8-13
Court: Northern District of California
Allegations:
New York, NY: A securities class action lawsuit has been filed in the United States District Court for the Northern District of California, on behalf of all persons who purchased or otherwise acquired the securities of Imperva, Inc. ("Imperva" or the "Company") during the period between May 2, 2013 and April 9, 2014 (the "Class Period").

The Complaint alleges that during the Class Period, Defendants issued materially false and misleading statements regarding the Company's operations and business and its financial results. The Complaint alleges that Imperva securities traded at artificially inflated prices during the Class Period, with its stock price reaching a high of $65.53 per share on March 6, 2014, and that the Company's top officers and directors were able to sell $25.9 million worth of their Imperva stock at inflated prices, including $11.8 million worth of stock sold by the Chief Executive Officer and the Chief Financial Officer.

On April 9, 2014, the Complaint alleges that the Company issued a press release announcing its preliminary first quarter 2014 financial results. The Company reported preliminary total revenue in the range of $31.0 to $31.5 million, which was below the Company's prior guidance of $36.0 to $37.0 million for the first quarter of 2014. Additionally the Company reported an expected net loss per share in the range of $(0.40) to $(0.44), below its prior guidance of $(0.33) to $(0.37) and a $(0.35) consensus estimate.

The Company blamed "'extended sales cycles on deals over $100,000,'" especially in the U.S., and stated that "'intensifi[ed] competition for large orders'" and sales execution issues contributed to the lengthy sales cycles. As a result of this news, Imperva's stock plummeted $21.73 per share to close at $28 per share on April 10, 2014, a one-day decline of nearly 44% on volume of 10.9 million shares.

If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Imperva, Inc. IMPV Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Imperva, Inc. securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.

Maybe it's your stockbroker

Add Your Comment on This Issue

Please read our comment guidelines before posting.


Note: Your name will be published with your comment.


Your email will only be used if a response is needed.

Request Legal Help